Department of Neurosurgery, School of Medicine, Kyungpook National University, Daegu, Republic of Korea 700-721.
Neurosurgery. 2010 May;66(5):904-8; discussion 908-9. doi: 10.1227/01.NEU.0000368385.74625.96.
This study investigated the outcome of early shunt placement in patients with poor-grade subarachnoid hemorrhage and the effect of intraventricular hemorrhage (IVH) and high proteinaceous cerebrospinal fluid (CSF) on subsequent shunt performance.
This study included 33 consecutive patients with initial Fisher grade (3/4) subarachnoid hemorrhage who had undergone conversion from external ventricular drainage (EVD) to a ventriculoperitoneal (VP) shunt and whose computed tomography scan showed IVH at the time of shunt placement. Early weaning from an EVD and conversion to a VP shunt was performed irrespective of IVH or high protein content in the CSF.
The mean interval from EVD to VP shunt placement was 6.4 days. The mean volume of IVH was 9.44 mL, and the mean value of IVH/whole ventricle volume ratio (ie, percentage of blood suspension in the CSF) was 9.81%. The mean perioperative protein level in the CSF was 149 mg/dL. During the follow-up period, 2 patients (6.1%) required VP shunt placement, and no patients experienced complications of ventriculitis or shunt-related infection.
Based on our data, earlier EVD weaning and shunt placement can effectively treat subarachnoid hemorrhage-induced hydrocephalus in patients with severe subarachnoid hemorrhage. This procedure resulted in no shunt-related infections and a 6.1% revision rate. There were fewer adverse effects of IVH and protein on shunt performance. Therefore, weaning from an EVD and conversion to a permanent VP shunt need not be delayed because of IVH or proteinaceous CSF.
本研究旨在探讨早期分流术对伴有较差级别蛛网膜下腔出血的患者的疗效,以及脑室内出血(IVH)和高蛋白性脑脊液(CSF)对随后分流器性能的影响。
本研究纳入了 33 例初始 Fisher 分级(3/4 级)蛛网膜下腔出血患者,这些患者接受了从外部脑室引流(EVD)转换为脑室腹膜(VP)分流的治疗,且在分流器放置时 CT 扫描显示存在 IVH。无论 CSF 中是否存在 IVH 或高蛋白含量,都可以早期从 EVD 中拔管并转换为 VP 分流。
EVD 到 VP 分流器放置的平均时间间隔为 6.4 天。IVH 的平均体积为 9.44mL,IVH/全脑室体积比(即 CSF 中血液悬浊物的比例)的平均值为 9.81%。CSF 中的平均围手术期蛋白水平为 149mg/dL。在随访期间,2 名患者(6.1%)需要进行 VP 分流器放置,没有患者出现脑室炎或与分流器相关的感染等并发症。
根据我们的数据,早期拔管和分流器放置可以有效地治疗严重蛛网膜下腔出血患者的蛛网膜下腔出血引起的脑积水。该治疗方法并未导致与分流器相关的感染和 6.1%的再手术率。IVH 和蛋白对分流器性能的不良影响较少。因此,不应该因为 IVH 或高蛋白性 CSF 而延迟从 EVD 拔管和转换为永久性 VP 分流。